As AMPK acts through Skp2 S256 phosphorylation and subsequent Akt activation to promote glucose metabolism, cancer cell migration, and VEGF expression in vitro, we then determined whether AMPK displays oncogenic activity in vivo and if so, whether it acts through promotion of Skp2 S256 phosphorylation. This evidence concerns the gene PRKAA1 and cancer.